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Edited by Michael R. SussmanAbstract Plasma membrane calcium/calmodulin-dependent
ATPases (PMCAs) are high aﬃnity calcium pumps that extrude
calcium from the cell. Emerging evidence suggests a novel role
for PMCAs as regulators of calcium/calmodulin-dependent sig-
nal transduction pathways via interaction with speciﬁc partner
proteins. In this work, we demonstrate that endogenous human
PMCA2 and -4 both interact with the signal transduction phos-
phatase, calcineurin, whereas, no interaction was detected with
PMCA1. The strongest interaction was observed between
PMCA2 and calcineurin. The domain of PMCA2 involved in
the interaction is equivalent to that reported for PMCA4b.
PMCA2–calcineurin interaction results in inhibition of the calci-
neurin/nuclear factor of activated T-cells signalling pathway.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Signalling; NFAT1. Introduction
Plasma membrane calcium P-type ATPases (PMCAs) are
high aﬃnity calcium pumps that contribute to the maintenance
of intracellular calcium homeostasis by exporting calcium
from the cytosol to the extracellular environment [1].
There are four diﬀerent isoforms of PMCA, numbered 1–4,
encoded by four independent genes. PMCA1 and PMCA4 are
expressed ubiquitously, whereas, PMCA2 and PMCA3 show a
more restricted cell- and tissue-speciﬁc pattern of expression [2].
Structurally, PMCAs consist of 10 transmembrane domains,
two big intracellular loops, and N- and C-terminal cytoplasmic
tails [2].Abbreviations: PMCA, plasma membrane calcium ATPase; NFAT,
nuclear factor of activated T-cells; HEK293, human embryonic kidney
cell; RIPA, radioimmunoprecipitation assay; TBS-T, Tris-buﬀered
saline plus Tween 20; PMA, phorbol-12 myristate 13-acetate
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doi:10.1016/j.febslet.2007.07.054The intracellular regions of PMCAs have been reported to
mediate functional interactions with calcium/calmodulin-
dependent enzymes, including nitric-oxide synthase I (nNOS)
[3], calcium/calmodulin-dependent serine protein kinase
(CASK) [4] and, calcineurin [5]. These interactions suggest that
PMCA might act as a regulator of signal transduction path-
ways by tethering signalling proteins to cellular microenviron-
ments where the concentrations of calcium and calmodulin are
maintained at low levels. In this sense, the interaction between
PMCA4 and calcineurin results in inhibition of the calcineurin/
nuclear factor of activated T-cells (NFAT) signal transduction
pathway [5].
The calcineurin/NFAT pathway plays a critical role in the
progression of several human pathologies [6]. At present, the
only clinically available inhibitors for the calcineurin/NFAT
pathway are the immunosuppressant drugs cyclosporine A
and FK506, which are unfortunately associated with severe
side eﬀects [7]. The recent identiﬁcation of ectopically ex-
pressed PMCA4 as an inhibitor of the calcineurin/NFAT path-
way [5] has prompted us to further investigate the interaction
between endogenous PMCA and calcineurin, and to extend
our previous observations to the analyses of other PMCA iso-
forms in an attempt to characterise new cellular inhibitors of
this pathway.
Here we demonstrate that the interaction between endo-
genous PMCA and calcineurin is isoform speciﬁc in MCF-7
human breast cancer cells. Endogenous PMCA2 and -4 both
interact with calcineurin, whereas, no interaction has been
detected for PMCA1. The strongest interaction was detected
between PMCA2 and calcineurin A. PMCA2 interacts with
calcineurin through a domain equivalent to that reported for
PMCA4b [5] and also inhibits the calcineurin/NFAT signalling
pathway.2. Materials and methods
2.1. Cell culture
Human embryonic kidney cell (HEK293) and MCF-7 cells were
maintained in Dulbecco’s modiﬁed Eagle’s medium (DMEM) (Sig-
ma–Aldrich) supplemented with 10% Fetal Calf Serum, 1% penicil-
lin/streptomycin and 1% L-Glutamine.blished by Elsevier B.V. All rights reserved.
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pFlag-PMCA4b-(428–651) has been described previously [5].
pcDNA3-hPMCA2b contains the human PMCA2b cDNA and was
a gift from Prof. Carafoli (University of Padova, Italy).
pcDNA3-hPMCA1b contains the human PMCA1b cDNA cloned
into the XhoI and KpnI cloning sites of pcDNA3.1(-) (Invitrogen).
A fragment of hPMCA2b encoding amino acids 462–684 was gener-
ated by 35 cycles of PCR (the conditions were denaturation at 94 C
for 30 s, annealing at 60 C for 1 min and extension at 72 C for
1 min) using oligonucleotides EcoPMCA2sense4 (5 0-TCTTCCggAA-
TTCTCCCgTCACCATCTCgTTgg-30) and BamPMCA2anti684 (5 0-
CTTggCggATCCTCACTCCgggCTgCTggggAAgTC-3 0) and plasmid
pcDNA3-hPMCA2b as a template.
A fragment of hPMCA2b cDNA encoding amino acids 1143–1243
was ampliﬁed by 35 cycles of PCR (the conditions were denaturation
at 94 C for 30 s, annealing at 56 C for 1 min and extension
at 72 C for 1 min) using oligonucleotides HindPMCA2sense1143
(5 0-TCTTCCCAAgCTTgTCgTgAAggCgTTCCgTAg-3 0) and Bam-
PMCA2anti1243 (5 0-CTTCgCggATCCTCAAAgCgACgTCTCCAgg-
CTgT-3 0) and plasmid pcDNA3-hPMCA2b as a template.
A fragment of hPMCA2b cDNA encoding amino acids 535–609 was
ampliﬁed by 35 cycles of PCR (the conditions were denaturation
at 94 C for 30 s, annealing at 60 C for 1 min and extension at
72 C for 1 min 30 s) using oligonucleotides HindPMCA2sense535
(5 0-TCTTCCCAAgCTTATggAgCTgCTgATCAATgCC-3 0) and Bam-
PMCA2anti609 (5 0-CTTCgCggATCCTCACATggACTTgCgCACg-
gAgTTg-3 0) and plasmid pcDNA3-hPMCA2b as a template.
Ampliﬁed fragments 462–684, 535–609 and 1143–1243 were digested
with EcoRI and BamHI, and HindIII and BamHI, respectively, and
cloned into the corresponding sites of p3xFlag-CMV7.1 (Sigma–
Aldrich). The resulting plasmids, pFlag-PMCA2b (462–684), pFlag-
PMCA2b (535–609) and pFlag-PMCA2b (1143–1243), encode
ﬂag-tagged PMCA2b truncated proteins containing amino acids
462–684, 535–609 and 1143–1243, respectively, (numbering according
to GenbankNM Accession No. NM_001683).
A fragment of hPMCA1b cDNA encoding amino acids 511–585 was
ampliﬁed by 35 cycles of PCR (the conditions were denaturation
at 94 C for 30 s, annealing at 56 C for 1 min and extension at
72 C for 1 min 30 s) using oligonucleotides EcoPMCA1sense511
(5 0-TCTTCCggAATTCTTTgTCCTATCTTgTAACAggAA-3 0) and
BamPMCA1anti585 (5 0-CTTCgCggATCCTCACATggACTTCCTA-
ACAgAATTg-3 0) and plasmid pcDNA3-hPMCA1b as a template.
Ampliﬁed fragment 511–585 was digested with EcoRI and
BamHI, and cloned into the corresponding sites of p3xFlag-CMV7.1
(Sigma–Aldrich). The resulting plasmid, pFlag-PMCA1b (511–585),
encodes a ﬂag-tagged PMCA1b truncated protein containing amino
acids 511–585 (numbering according to GenbankNM Accession No.
J04027).
The ﬁdelity of all ampliﬁed products was conﬁrmed by sequencing.WB:α-PMCA4
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Fig. 1. The interaction between endogenous PMCA and calcineurin A
in human breast adenocarcinoma MCF-7 cells is isoform speciﬁc. Co-2.3. Transient transfections
For immunoprecipitation experiments, HEK 293 cells were plated in
100 · 20-mm tissue culture dishes (4.5 · 106 cells/plate) the day before
transfection. Cells were transfected with 10 lg of the indicated expres-
sion plasmids by using LipofectAMINE 2000 reagent (Invitrogen) as
previously described [8].
For luciferase assays, HEK293 cells were plated in 6-well tissue cul-
ture plates (0.5 · 106 cells/well) the day before transfection. Cells were
transfected with 10 lg of an expression vector encoding human
PMCA2b (pcDNA3-hPMCA2b) or the corresponding empty vector
(pcDNA3) and 5 lg of the luciferase reporter pNFAT-TA-Luc (Clon-
tech) by using LipofectAMINE2000 reagent (Invitrogen) as previously
described [8]. Cells were stimulated with phorbol-12 myristate 13-ace-
tate (PMA) (20 ng/ml) and the calcium ionophore A23187 (1 lM) for
16 h and luciferase activity determined as described [8]. Transfection
eﬃciency was normalised by co-transfection of plasmid pEF-LacZ
and determination of b-galactosidase activity [9].precipitation of PMCA2 or PMCA4 (but not PMCA1) and calcineurin
using an antibody against calcineurin A demonstrates the physical
interaction between the two proteins in MCF-7 cells. (a-CnA) anti-
calcineurin A monoclonal antibody, (5F10) anti-PMCA monoclonal
antibody, (a-luc) anti-luciferase antibody. Western blots of immuno-
precipitated proteins were probed with antibodies speciﬁc for PMCA1,
PMCA2, or PMCA4 (Swant) to detect PMCA1 (WB: PMCA1),
PMCA2 (WB: PMCA2) and PMCA4 (WB: PMCA4), respectively.2.4. Immunoprecipitation
MCF-7 or transfected HEK293 cells were lysed as described [5]. One
milliliter extracts were incubated overnight with the corresponding
immunoprecipitating antibodies and 40 ll of protein A-agarose beads
(Roche), at 4 C with shaking. Beads were recovered by centrifugation
at 3000 rpm and washed three times with 500 ll of radioimmunopre-cipitation assay (RIPA) buﬀer. Washed beads were resuspended in
60 ll of 2 · SDS–PAGE loading buﬀer (Invitrogen) and analyzed by
Western blot.
2.5. Western blot
Samples were boiled and resolved as previously described [5]. Wes-
tern blot membranes were incubated at room temperature with a
0.1% (v/v) solution of anti-Flag M2 peroxidase-conjugated monoclo-
nal antibody (Sigma–Aldrich) in Tris-buﬀered saline plus Tween 20
(TBS-T) (for Flag-epitope detection) or with a 0.25% (v/v) solution
of isoform speciﬁc rabbit polyclonal anti-PMCA antibody (Swant)
for detection of the corresponding isoform of PMCA for 3 h. Bound
antibodies were detected by ECL as described [5].3. Results
3.1. Co-precipitation of endogenous human PMCA and
calcineurin A in human breast adenocarcinoma cells
To investigate the interaction between endogenous PMCA
isoforms 1, 2 or 4 and calcineurin A in human breast adenocar-
cinoma cells, protein extracts were immunoprecipitated with a
monoclonal anti-calcineurin A antibody (Sigma) and precipi-
tated proteins were probed by western blot using isoform spe-
ciﬁc anti-PMCA antibodies (Swant).
A very faint but reproducible band corresponding to
PMCA4 was detected in samples probed with a rabbit anti-
PMCA4 antibody (Fig. 1, upper panel) suggesting a weak
interaction between endogenous calcineurin A and human
PMCA4 in MCF-7 cells. Control immunoprecipitations car-
ried out with the 5F10 anti-PMCA monoclonal antibody re-
vealed the presence of high levels of the PMCA4 isoform in
MCF-7 cells (Fig. 1, upper panel) indicating that the weak
band detected was not attributable to low expression levels
of PMCA4 or low aﬃnity of the antibody.
Western blot with an anti-PMCA2 antibody showed high
levels of co-precipitated PMCA2 (Fig. 1, middle panel) sug-
gesting a strong interaction between endogenous calcineurin
A and human PMCA2.
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tate PMCA1 in MCF-7 cells as evidenced by the absence of
PMCA1 detection when the precipitated proteins were probed
with an antibody recognising speciﬁcally PMCA1 (Fig. 1,
lower panel). This ﬁnding suggests a lack of interaction be-
tween endogenous calcineurin A and PMCA1 in human
MCF-7 cells. Immunoprecipitation performed with the 5F10
anti-PMCA antibody precipitated high levels of PMCA1 pro-
tein (Fig. 1, lower panel) ruling out low expression levels of
PMCA1 as the cause for lack of interaction with calcineurin A.
In all cases, control immunoprecipitations carried out with
an irrelevant antibody (anti-luciferase) precipitated no protein
at all, conﬁrming the selectivity of the interactions (Fig. 1).
In summary, these results indicate that the interaction
between endogenous calcineurin A and PMCAs is isoform
speciﬁc and suggest that calcineurin A interacts very strongly
with endogenous PMCA2 but very weakly with PMCA4 in
human breast adenocarcinoma cells.
3.2. The region 462–684 of PMCA2b is essential for interaction
with calcineurin A
We have previously reported that the region encompassing
amino acids 428–651 of human PMCA4b is involved in the
interaction with calcineurin A [5]. Comparison of the sequence
for the equivalent region in PMCA2b revealed a high degree
(76%) of amino acid homology suggesting that this regionWB:α-Flag
WB:α-Flag
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Fig. 2. The region 462–684 of human PMCA2b interacts with calcineurin A.
C-terminal (amino acids 1143–1243) intracellular region of human PMCA2
(428–651) in the PMCA4b catalytic domain, and the small interaction do
hPMCA1b. (B) Immunoprecipitation analysis of the interaction between calc
462–684, located within the catalytic big intracellular loop of PMCA2b, spe
amino acids 539–609 of hPMCA2b still interacts with calcineurin, however, t
with calcineurin.might be involved in the interaction with calcineurin A. To test
this hypothesis, we generated FLAG-tagged fusion proteins
containing the region spanning amino acids 462–684, or
1143–1243 of PMCA2b (Fig. 2A).
HEK293 cells were transfected with plasmids pF-PMCA2b-
(462–684) or -(1143–1243). Commercially available calcineurin
A (Sigma) was added to the protein lysates to a ﬁnal concen-
tration 40 nM. Protein lysates were then immunoprecipitated
by overnight incubation with monoclonal anti-calcineurin A
antibody, and, subsequently, probed by western blot. FLAG-
PMCA2b-(462–684) co-precipitated with calcineurin A
(Fig. 2B, left upper panel). No precipitation was observed
for FLAG-PMCA2b-(1143–1243) demonstrating the selectiv-
ity of the interaction (Fig. 2B, left upper panel). Cells transfec-
ted with pF-PMCA4b-(428–651) were used as a positive
control (Fig. 2B, left upper panel) [5]. These results demon-
strate that the region 462–684 of the catalytic large intracellu-
lar loop of PMCA2b is implicated in the interaction with
calcineurin A.
Our previous observations for human PMCA4b suggested
that the fragment 501–575 of PMCA4b is essential for the
interaction of this protein with calcineurin [5]. To test the abil-
ity of the equivalent region in hPMCA2b (fragment 535–609)
to interact with calcineurin we generated a Flag-tagged fusion
protein containing this region (Fig. 2A). Flag-hPMCA2b(535–
609) co-precipitated with calcineurin (Fig. 2B, right upperWB:α-Flag
WB:α-FlagExpression levels
mmunoprecipitated proteins
(A) Schematic representation of FLAG-tagged proteins containing; the
b, the region 462–684 of its catalytic domain or the equivalent region
main 539–609 of hPMCA2b or the equivalent region (511–585) in
ineurin A and the FLAG–tagged proteins described above. The region
ciﬁcally interacts with calcineurin A. A small fragment encompassing
he equivalent sequence of hPMCA1b (511–585) failed to co-precipitate
4118 M. Holton et al. / FEBS Letters 581 (2007) 4115–4119panel) although to a lesser degree than that observed with the
full fragment (462–684) suggesting that adjacent sequences
might contribute to the interaction. This result indicates that
the region 535–609 of PMCA2b interacts with calcineurin.
A Flag-tagged fusion protein containing the equivalent se-
quence for hPMCA1b, Flag-hPMCA1b(511–585) (Fig. 2A),
failed to co-precipitate with calcineurin (Fig. 2B, right upper
panel), conﬁrming the lack of interaction observed between
endogenous PMCA1 and calcineurin.
Western blot analysis of the protein lysates prior to immuno-
precipitation showed expression of the corresponding Flag-
tagged fusion proteins, disproving that lack of expression
may have led to a lack of interaction (Fig. 2B, lower panels).
3.3. PMCA2b signiﬁcantly inhibits NFAT transcriptional
activity
Previous investigations have reported that PMCA4b nega-
tively regulates the activity of endogenous calcineurin A in
mammalian cells [5]. We speculated that PMCA2 could also
function as an inhibitor of the calcineurin/NFAT pathway.
HEK293 cells were co-transfected with pcDNA3 (empty
plasmid) and the NFAT-dependent luciferase reporter vector
pNFAT-TA-Luc (Clontech) and then stimulated with PMA
and the calcium ionophore A23987 (Io) to induce calcineurin A
activation and consequent NFAT transcriptional activity. Co-
transfection of pNFAT-TA-Luc with pcDNA3-hPMCA2b, an
expression plasmid encoding hPMCA2b, signiﬁcantly reduced
(32% inhibition, P  0.05) PMA plus Io-dependent activation
of the luciferase reported vector (Fig. 3). These results suggest
that PMCA2b negatively regulates the activity of endogenous
calcineurin A in mammalian cells.0
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Fig. 3. PMCA2b signiﬁcantly inhibits NFAT transcriptional activity.
PMCA2b inhibits the activation of an NFAT-dependent luciferase
reporter vector in response to PMA plus Calcium ionophore (Io)
A23187. 10 lg of pcDNA3-hPMCA2b, pcDNA3-hPMCA1b or con-
trol vector pcDNA3, and 5 lg of the NFAT-dependent luciferase
reporter vector pNFAT-TA-Luc were co-transfected in HEK293 cells.
Cells were stimulated with PMA (20 ng/ml) plus Io (1 lM) for 16 h.
Induction after PMA/Io stimulation of reporter vector luciferase
activity in the presence of co-transfected control plasmid pcDNA3 was
taken as reference (100%). Co-expression of human PMCA2b resulted
in a signiﬁcant reduction (32% inhibition) of luciferase induction.
However, co-expression of human PMCA1b did not result in
inhibition of the luciferase reporter vector. *, statistically signiﬁcant
(P 6 0.05, according to Student’s t-test). Means ± S.E. of three
independent experiments are shown.In agreement with the lack of interaction observed between
endogenous hPMCA1b and calcineurin, co-transfection of
pNFAT-TA-Luc with pcDNA3-hPMCA1b, an expression
plasmid encoding human PMCA1b, did not result in inhibition
of the luciferase reporter vector (Fig. 3).4. Discussion
In this investigation we have shown that the interaction
between endogenous PMCA and calcineurin is isoform speciﬁc
in MCF-7 breast adenocarcinoma cells. A strong interaction
was detected between PMCA2 and calcineurin A. Expression
of PMCA2 leads to inhibition of the calcineurin/NFAT
pathway.
Emerging evidence indicates a major role for PMCA2 in
mammary gland physiology; PMCA2b is highly expressed in
lactating mammary tissues [10], mice homozygous for a null-
mutation of the pmca2 gene produced milk with 60% less cal-
cium than wild type animals [11] and expression of PMCA2 is
up-regulated in breast cancer cell lines [12]. These ﬁndings sug-
gest that deregulation of PMCA might contribute to breast
tumorigenesis.
In this work, we demonstrate that PMCA2 inhibits the
calcineurin/NFAT pathway. Increased PMCA2 expression in
breast cancer is, therefore, expected to inhibit the calcineu-
rin/NFAT pathway. High calcineurin activity leads to apopto-
sis [13] thereby, PMCA2-mediated down-regulation of
calcineurin activity might result in inhibition of apoptosis
and promotion of tumorigenesis in cancer cells. In agreement
with this hypothesis, Padma et al. [14] have shown that calci-
neurin activity is down-regulated in cervical carcinoma. It
would be interesting to analyse the level of PMCA2 expression
in these cells and determine if it regulates calcineurin activity
and, therefore, apoptosis in cervical carcinomas.
PMCA2-mediated inhibition of calcineurin and, therefore,
calcineurin-mediated apoptosis, may also be involved in the
hearing deﬁcits observed in PMCA2-deﬁcient mice [15]. High
levels of PMCA2 have been found in the outer hair cells of
the cochlea [16]. Impairment by mutation of PMCA2 function
in deafwaddler mice (dfw/dfw) results in apoptotic hair cell
death [17]. Lack of functional PMCA2 in the deafwaddler
mouse might lead to an increase in calcineurin activity that
would result in calcineurin-mediated apoptosis of outer hair
cells. In accordance with this hypothesis, heightened activity
of calcineurin has been shown to increase apoptosis of outer
hair cells and promote cochlear acoustic injury [18]. Moreover,
Minami et al. [19] have reported that the calcineurin inhibitors,
FK506 and cyclosporine A, reduce noise-induced hair cell
death. Therefore, it is highly probable that the interaction be-
tween PMCA and calcineurin is a major regulator of apoptosis
in hair cells.
In conclusion, our results demonstrate that the interaction
between endogenous PMCA and calcineurin is isoform-speciﬁc
in MCF-7 adenocarcinoma cells and suggest that this interac-
tion might play an important role in the regulation of breast
tumorigenesis and hearing loss.Acknowledgements: We thank Prof. Ernesto Carafoli (University of
Padova, Italy) for providing the pcDNA3-hPMCA2b plasmid. M.H.
is the recipient of a PhD studentship funded by the Research Institute
in Healthcare Science, University of Wolverhampton.
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